AAS
AVXL icon

Ameritas Advisory Services’s Anavex Life Sciences AVXL Stock Holding History

Ameritas Advisory Services’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-100
Closed -$857 – 687
2023
Q1 		$857 Buy
+100
New +$998 ﹤0.01% 2572

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Ameritas Advisory Services's AVXL Position: Q2 2023 in Review

Ameritas Advisory Services sold out of Anavex Life Sciences (AVXL) in Q2 2023, closing a stake of 100 shares — an estimated $857 sold.

Ameritas Advisory Services first reported a position in AVXL in Q1 2023 and held it in 1 quarter. The position peaked at $857 in Q1 2023. 144 funds tracked by Wall St. Rank hold AVXL as of Q2 2023.

  • Ameritas Advisory Services reported no remaining Anavex Life Sciences position as of Q2 2023 after selling out during the quarter.
  • Ameritas Advisory Services sold 100 Anavex Life Sciences shares in Q2 2023, an estimated $857.
  • Ameritas Advisory Services first reported a position in Anavex Life Sciences in Q1 2023 and held it in 1 quarter.
  • Ameritas Advisory Services's Anavex Life Sciences position peaked at $857 in Q1 2023.
  • 144 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2023.

Based on Ameritas Advisory Services's 13F filing for Q2 2023, filed 25 Jul 2023.